BridgeBio Pharma Market Cap

BridgeBio Pharma has a market cap or net worth of $6.44 billion as of April 17, 2025. Its market cap has increased by 19.48% in one year.

Market Cap

6.44B

Enterprise Value

7.49B

1-Year Change

19.48%

Ranking

#1052

Market Cap Chart

Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $6.44B, an increase of 94.04%. That is a compound annual growth rate of 12.08%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2025	6.44B	24.22%
Dec 31, 2024	5.19B	-26.16%
Dec 29, 2023	7.02B	516.56%
Dec 30, 2022	1.14B	-53.61%
Dec 31, 2021	2.46B	-71.83%
Dec 31, 2020	8.72B	101.23%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	754.27B
UnitedHealth Group	415.38B
Johnson & Johnson	379.48B
AbbVie	306.02B
Novo Nordisk	284.50B
Abbott Laboratories	227.16B
Novartis AG	209.93B
AstraZeneca	208.11B

Market Cap Rankings